Shionogi
Clinical trials sponsored by Shionogi, explained in plain language.
A Japanese pharmaceutical company focused on infectious diseases and pain management.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New RSV drug trial aims to protect vulnerable adults
Disease control Recruiting nowThis study tests an experimental antiviral drug called S-337395 in adults with RSV who are at high risk for severe illness. Participants must have symptoms for less than 72 hours and a confirmed RSV infection. The goal is to see if the drug can lower the amount of virus in the bo…
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New pill could boost breathing in pompe disease – early trial underway
Disease control Recruiting nowThis study tests an experimental oral drug called S-606001 in 45 adults with late-onset Pompe disease. Participants take the drug or a placebo on top of their standard enzyme replacement therapy. The main goal is to see if the drug improves lung function and walking ability over …
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called S-531011, alone or with other cancer treatments, in people with advanced solid tumors that have not responded to standard therapies. The goal is to find safe doses and see if the drug can shrink tumors or slow their growth. About 282 adults with…
Phase: PHASE1, PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for kids on painkillers: constipation relief drug under study
Symptom relief Recruiting nowThis study is testing a medicine called naldemedine to help children who get constipated from taking opioids (strong painkillers). About 24 children with cancer or other pain conditions will receive a single dose of the drug. Researchers will measure how the drug moves through th…
Phase: PHASE1, PHASE2 • Sponsor: Shionogi • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC